Laura Perin Gallandt, PhD
|
| Title(s) | Associate Professor of Research Urology |
|---|
| School | Keck School of Medicine of Usc |
|---|
| Address | CHL MailStop 35
Off Campus
Los Angeles CA 90089
|
|---|
| Phone | +1 323 361 8435 |
|---|
| Email | lperin@chla.usc.edu |
|---|
| vCard | Download vCard |
|---|
|
|
| Title(s) | Vice Chair of Research, Surgery at CHLA |
|---|
|
|---|
|
Overview
Dr. Laura Perin is an Associate Professor at Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California. Dr Perin obtained a master’s degree in Biological Sciences at the University of Padova, and a Ph.D. in Stem cells and Tissue Engineering at the Harvard School of Medicine. Dr. Perin’s research is focused on studying the mechanisms that regulate kidney damage, with specific attention to glomerular injuries. Dr Perin uses different regenerative approaches including extracellular vesicles, stem cells, organ a chip technology, and development biology to understand the molecular mechanisms that modulate renal regeneration. Dr. Perin has received many intramural and extramural awards and has published more than 70 articles in the field of renal regeneration.
ORNG Applications
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Effect of disease progression on the podocyte cell cycle in Alport Syndrome. Kidney Int. 2022 01; 101(1):106-118.
Frank CN, Hou X, Petrosyan A, Villani V, Zhao R, Hansen JR, Clair G, Salem F, De Filippo RE, Cravedi P, Lemley KV, Perin L. PMID: 34562503.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansAnimalsCells
-
Author Correction: A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier. Nat Commun. 2019 Oct 21; 10(1):4791.
Petrosyan A, Cravedi P, Villani V, Angeletti A, Manrique J, Renieri A, De Filippo RE, Perin L, Da Sacco S. PMID: 31636254; PMCID: PMC6803622.
View in:
PubMed Mentions:
4 Fields:
-
A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier. Nat Commun. 2019 08 13; 10(1):3656.
Petrosyan A, Cravedi P, Villani V, Angeletti A, Manrique J, Renieri A, De Filippo RE, Perin L, Da Sacco S. PMID: 31409793; PMCID: PMC6692336.
View in:
PubMed Mentions:
94 Fields:
Translation:
HumansCells
-
Amniotic fluid stem cell-derived vesicles protect from VEGF-induced endothelial damage. Sci Rep. 2017 12 04; 7(1):16875.
Sedrakyan S, Villani V, Da Sacco S, Tripuraneni N, Porta S, Achena A, Lavarreda-Pearce M, Petrosyan A, Soloyan H, Filippo RE, Bussolati B, Perin L. PMID: 29203902; PMCID: PMC5715019.
View in:
PubMed Mentions:
36 Fields:
Translation:
AnimalsCells
-
A step towards clinical application of acellular matrix: A clue from macrophage polarization. Matrix Biol. 2017 01; 57-58:334-346.
Petrosyan A, Da Sacco S, Tripuraneni N, Kreuser U, Lavarreda-Pearce M, Tamburrini R, De Filippo RE, Orlando G, Cravedi P, Perin L. PMID: 27575985; PMCID: PMC6717660.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansAnimalsCells
-
Amniotic fluid stem cells prevent β-cell injury. Cytotherapy. 2014 Jan; 16(1):41-55.
Villani V, Milanesi A, Sedrakyan S, Da Sacco S, Angelow S, Conconi MT, Di Liddo R, De Filippo R, Perin L. PMID: 24210784; PMCID: PMC4374982.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimalsCells
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs